JPH09184690A - Cooling tower for air conditioner - Google Patents

Cooling tower for air conditioner

Info

Publication number
JPH09184690A
JPH09184690A JP27971096A JP27971096A JPH09184690A JP H09184690 A JPH09184690 A JP H09184690A JP 27971096 A JP27971096 A JP 27971096A JP 27971096 A JP27971096 A JP 27971096A JP H09184690 A JPH09184690 A JP H09184690A
Authority
JP
Japan
Prior art keywords
water
release cartridge
cooling tower
sustained release
drug sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP27971096A
Other languages
Japanese (ja)
Inventor
Hironori Hatono
広典 鳩野
Takao Imasaka
卓男 今坂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toto Ltd
Original Assignee
Toto Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toto Ltd filed Critical Toto Ltd
Priority to JP27971096A priority Critical patent/JPH09184690A/en
Publication of JPH09184690A publication Critical patent/JPH09184690A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nozzles (AREA)

Abstract

PROBLEM TO BE SOLVED: To sterilize cooling water for an air conditioner periodically by releasing water soluble liquid germicide or the saturated water solution of it inside a controlled release medicine cartridge to the city water that flows through distributing water pipes in the supply of the city water to a cooling tower. SOLUTION: The city water that flows into the controlled release medicine cartridge 2, proceeds towards the closed edge at the central part, diffuses radially and flows toward the opening edge of the controlled release medicine cartridge 2 as a cylindrical flow along the wall of the circumference of it. In the process of it, the germicide solves into the city water and the city water becomes the saturated solution of the germicide. The germicide solution flows out through the porous film 2a that covers the opening end of the controlled release medicine cartridge 2 to the outside and is mixed with the city water flowing by. The city water that is mixed with the saturated solution of the germicide flows into the supply distribution pipes 1 at the down flow of the bulged part 1a and then flows into the cooling tower. As the result of it, the germicide is added to the cooling water for the air conditioner periodically and sterilizes it.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は空調用クーリングタ
ワーに関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cooling tower for air conditioning.

【0002】[0002]

【従来の技術】空調用クーリングタワーは、ビル等の空
調に使用され温水化した冷却水を、空気流に接触させて
一部を蒸発させ、蒸発の際の気化熱を利用して残余の温
水化した冷却水を冷却し、冷却された冷却水をビル等の
内部へ還流させる装置である。温水化した冷却水の一部
が空調用クーリングタワー内で蒸発し大気中へ放出され
るので、空調用クーリングタワーには、大気中へ放出さ
れた冷却水を補うための補給水用配水管が取り付けられ
ており、空調用クーリングタワーの底部溜まった冷却後
の冷却水の水位が低下すると、フロート弁によって水位
の低下を検知し、補給水用配水管を通って水道水が空調
用クーリングタワーへ供給されるようになっている。
2. Description of the Related Art A cooling tower for air conditioning uses cooling water that has been used for air conditioning of buildings, etc., which has been warmed to bring it into contact with an air flow to partially evaporate it, and to use the heat of vaporization during evaporation to heat the remaining water. It is a device that cools the cooled cooling water and returns the cooled cooling water to the inside of a building or the like. Part of the warmed cooling water evaporates inside the air conditioning cooling tower and is released into the atmosphere.Therefore, a makeup water distribution pipe is attached to the cooling tower for air conditioning to supplement the cooling water released into the atmosphere. Therefore, when the water level of the cooling water after cooling that has accumulated at the bottom of the cooling tower for air conditioning drops, a drop in the water level is detected by the float valve, and tap water is supplied to the cooling tower for air conditioning through the distribution pipe for makeup water. It has become.

【0003】[0003]

【発明が解決しようとする課題】クーリングタワー内に
発生するレジオネラ菌が気管支炎、肺炎等を引き起こし
問題となっている。本発明は上記の問題点に鑑みてなさ
れたものであり、冷却水が定期的に殺菌されるクーリン
グタワーを提供することを目的とする。
Problems to be Solved by the Invention Legionella bacteria occurring in the cooling tower cause bronchitis, pneumonia, etc., which is a problem. The present invention has been made in view of the above problems, and an object thereof is to provide a cooling tower in which cooling water is regularly sterilized.

【0004】[0004]

【課題を解決するための手段】前記課題を解決するため
に、本発明においては、補給水用配水管と、補給水用配
水管が接続するクーリングタワー本体と、水溶性の液状
の殺菌剤又は水溶性の殺菌剤と該殺菌剤の飽和水溶液と
が充填された空気層を含まない硬質材容器と、硬質材容
器に形成された単一の開口と、該開口を覆う多孔質膜と
を有する薬剤徐放カートリッジとを備え、薬剤徐放カー
トリッジは前記開口を補給水用配水管の流路に連通さ
せ、且つ前記開口を前記流路の上流側へ差し向けた状態
で補給水用配水管に装着されていることを特徴とする空
調用クーリングタワーを提供する。
In order to solve the above-mentioned problems, in the present invention, a make-up water distribution pipe, a cooling tower body to which the make-up water distribution pipe is connected, a water-soluble liquid germicide or a water-soluble disinfectant. Agent having a hard material container not filled with an air layer filled with a water-soluble bactericide and a saturated aqueous solution of the bactericide, a single opening formed in the hard material container, and a porous film covering the opening A sustained-release cartridge, wherein the drug sustained-release cartridge is attached to the makeup water distribution pipe with the opening communicating with the flow passage of the makeup water distribution pipe and the opening facing the upstream side of the passage. A cooling tower for air conditioning is provided.

【0005】本発明に係る空調用クーリングタワーにお
いては、補給水用配水管を通って水道水がクーリングタ
ワーへ供給される際に、補給水用配水管を流れる水道水
の一部が、薬剤徐放カートリッジに形成された単一の開
口を通って、薬剤徐放カートリッジ内に洗浄水が侵入
し、薬剤徐放カートリッジ内の水溶性の液状の殺菌剤又
は水溶性の殺菌剤の飽和水溶液が、前記単一の開口を通
って、配水管を流れる水道水中へ放出される。薬剤徐放
カートリッジの開口は多孔質膜によって覆われており、
薬剤徐放カートリッジ内には圧力変動によって体積が変
化する空気が存在せず、薬剤徐放カートリッジは硬質材
で形成され外圧を加えても変形しないので、薬剤徐放カ
ートリッジ内の水溶性の液状の殺菌剤又は水溶性の殺菌
剤の飽和水溶液は、過剰放出されることなく安定して補
給水用配水管を流れる水道水中に徐放される。殺菌剤が
添加された水道水は補給水用配水管を通って空調用クー
リングタワーへ流入する。この結果、空調用冷却水に定
期的に殺菌剤が添加され、空調用冷却水が定期的に殺菌
される。水溶性の液状の殺菌剤又は水溶性の殺菌剤の飽
和水溶液は安定して補給水用配水管を流れる水道水中に
徐放されるので、本発明に係る空調用クーリングタワー
を使用すれば、空調設備の循環ラインを長期に亘って殺
菌できる。
In the cooling tower for air conditioning according to the present invention, when tap water is supplied to the cooling tower through the makeup water distribution pipe, a part of the tap water flowing through the makeup water distribution pipe is a drug sustained release cartridge. The wash water penetrates into the drug sustained-release cartridge through the single opening formed in the cartridge, and the water-soluble liquid disinfectant or the saturated aqueous solution of the water-soluble disinfectant in the drug sustained-release cartridge is discharged to the above single unit. The water is discharged into the tap water flowing through the water pipe through one opening. The opening of the drug sustained release cartridge is covered with a porous film,
Since there is no air whose volume changes due to pressure fluctuations in the drug sustained-release cartridge, and the drug sustained-release cartridge is formed of a hard material and does not deform even when external pressure is applied, the drug sustained-release cartridge contains a water-soluble liquid. The bactericidal agent or a saturated aqueous solution of a water-soluble bactericidal agent is stably released into the tap water flowing through the makeup water distribution pipe without being released excessively. The tap water to which the bactericide is added flows into the cooling tower for air conditioning through the distribution pipe for makeup water. As a result, the sterilizing agent is added to the cooling water for air conditioning at regular intervals, and the cooling water for air conditioning is regularly sterilized. Since a water-soluble liquid germicide or a saturated aqueous solution of a water-soluble germicide is stably released into tap water flowing through a distribution pipe for makeup water, if an air conditioning cooling tower according to the present invention is used, The circulation line can be sterilized for a long time.

【0006】本発明の好ましい態様においては、薬剤徐
放カートリッジは補給水用配水管の外側に装着され、薬
剤徐放カートリッジの開口近傍部は補給水用配水管内へ
差し込まれている。薬剤徐放カートリッジを補給水用配
水管の外側に装着することにより、薬剤徐放カートリッ
ジの交換が容易になる。
In a preferred embodiment of the present invention, the drug sustained release cartridge is mounted outside the makeup water distribution pipe, and the vicinity of the opening of the drug sustained release cartridge is inserted into the makeup water distribution pipe. By mounting the drug sustained release cartridge on the outside of the makeup water distribution pipe, replacement of the drug sustained release cartridge becomes easy.

【0007】本発明の好ましい態様においては、薬剤徐
放カートリッジは一端が閉鎖され他端が開放された筒体
であり、薬剤徐放カートリッジは補給水用配水管内に配
設されており、薬剤徐放カートリッジと補給水用配水管
の囲壁との間に隙間がある。一端が閉鎖され他端が開放
された筒体から成る薬剤徐放カートリッジを補給水用配
水管内に配設し、薬剤徐放カートリッジと補給水用配水
管の囲壁との間に隙間を形成することにより、薬剤徐放
カートリッジが補給水用配水管によって保護され、外力
によって薬剤徐放カートリッジが破損する等の事故の発
生が防止される。
In a preferred embodiment of the present invention, the drug sustained-release cartridge is a cylindrical body having one end closed and the other end opened, and the drug sustained-release cartridge is disposed in a make-up water distribution pipe. There is a gap between the discharge cartridge and the surrounding wall of the makeup water distribution pipe. Disposing a medicine sustained release cartridge consisting of a cylinder with one end closed and the other end open in a makeup water distribution pipe, and forming a gap between the medicine sustained release cartridge and the surrounding wall of the makeup water distribution pipe. As a result, the medicine sustained release cartridge is protected by the makeup water distribution pipe, and an accident such as damage to the medicine sustained release cartridge due to external force is prevented.

【0008】本発明の好ましい態様においては、空調用
クーリングタワーは補給水用配水管から薬剤徐放カート
リッジへ流入する水量を調節する水量調節装置を備え
る。補給水用配水管から薬剤徐放カートリッジへ流入す
る水量を調節する水量調節装置を配設することにより、
殺菌剤の徐放量の調節が可能となる。
In a preferred embodiment of the present invention, the cooling tower for air conditioning is provided with a water amount adjusting device for adjusting the amount of water flowing into the medicine sustained release cartridge from the makeup water distribution pipe. By arranging a water amount adjusting device that adjusts the amount of water flowing from the makeup water distribution pipe to the drug sustained release cartridge,
It is possible to control the sustained release amount of the bactericide.

【0009】本発明の好ましい態様においては、空調用
クーリングタワーは空調用クーリングタワーの停止時
に、薬剤徐放カートリッジから殺菌剤が漏出するのを防
止する殺菌剤漏出防止装置を備える。空調用クーリング
タワーの停止時に薬剤徐放カートリッジから殺菌剤が漏
出するのを防止する殺菌剤漏出防止装置を配設すること
により、空調用クーリングタワーの停止時に補給水用配
水管内の残留水中に殺菌剤が漏出し、早期に殺菌剤が用
尽される事態の発生が防止される。
In a preferred embodiment of the present invention, the air conditioning cooling tower is equipped with a sterilizing agent leakage prevention device for preventing leakage of the sterilizing agent from the medicine sustained release cartridge when the air conditioning cooling tower is stopped. By installing a disinfectant leakage prevention device that prevents the disinfectant from leaking from the chemical release cartridge when the cooling tower for air conditioning is stopped, when the cooling tower for air conditioning is stopped, the disinfectant remains in the residual water in the distribution pipe for makeup water. Leakage and the occurrence of the situation where the bactericide is exhausted early are prevented.

【0010】[0010]

【発明の実施の形態】本発明の第1実施例に係る空調用
クーリングタワーを図1、2に基づいて説明する。図1
に示す空調用クーリングタワーは、補給水用配水管1を
備えている。補給水用配水管1の途上に、膨出部1aが
形成されている。膨出部1aに薬剤徐放カートリッジ2
が装着されている。補給水用配水管1の上流端は水道配
管に接続されている。配水管1の下流端はクーリングタ
ワー本体3に接続されている。クーリングタワー本体3
内には、図示しない散水装置、送風ファン、フロート弁
等が配設されている。空調設備の循環水配管4a、4b
がクーリングタワー本体3に接続されている。循環水配
管4bの途上にポンプ5が配設されている。
DESCRIPTION OF THE PREFERRED EMBODIMENTS An air conditioning cooling tower according to a first embodiment of the present invention will be described with reference to FIGS. FIG.
The cooling tower for air conditioning shown in (1) is provided with a distribution pipe 1 for makeup water. A bulging portion 1a is formed on the way of the makeup water distribution pipe 1. The drug sustained release cartridge 2 is attached to the bulging portion 1a.
Is installed. The upstream end of the makeup water distribution pipe 1 is connected to a water pipe. The downstream end of the water distribution pipe 1 is connected to the cooling tower body 3. Cooling tower body 3
Inside, a water sprinkler, a blower fan, a float valve, and the like, which are not shown, are arranged. Circulating water piping 4a, 4b for air conditioning equipment
Is connected to the cooling tower body 3. A pump 5 is arranged on the way of the circulating water pipe 4b.

【0011】薬剤徐放カートリッジ2の装着状態を、図
2に基づいて詳述する。接続金具6が、膨出部1aと、
膨出部1aの上流側の補給水用配水管1の下流端とに螺
合している。膨出部1aから、膨出部1aの下流側の補
給水用配水管1が延びている。膨出部1aに、空気弁7
と水抜弁8とが取り付けられている。殺菌剤の粉末又は
粒状体と殺菌剤の飽和水溶液とによって満たされ、内部
に圧縮性の空気が存在しない、アクリル樹脂等の硬質材
料から成り、一端が開放され、開放端が多孔質膜2aで
覆われた筒状の薬剤徐放カートリッジ2が、膨出部1a
の外側に装着されている。薬剤徐放カートリッジ2の開
放端近傍部は、膨出部1aに取り付けられた揺動蓋9を
押し開いて、膨出部1a内へ差し込まれている。薬剤徐
放カートリッジ2の開放端は、接続金具6の下流端に向
かい合っている。
The mounting state of the sustained drug release cartridge 2 will be described in detail with reference to FIG. The connection fitting 6 has a bulge portion 1a,
It is screwed to the downstream end of the makeup water distribution pipe 1 on the upstream side of the bulging portion 1a. A make-up water distribution pipe 1 on the downstream side of the bulging portion 1a extends from the bulging portion 1a. The air valve 7 is attached to the bulging portion 1a.
And a drain valve 8 are attached. It is made of a hard material such as acrylic resin, which is filled with a powder or granules of a germicide and a saturated aqueous solution of the germ, and has no compressible air inside, and has one end open and the open end being a porous membrane 2a. The covered cylindrical drug sustained-release cartridge 2 has a bulging portion 1a.
Is mounted on the outside of. The swinging lid 9 attached to the bulging portion 1a is pushed open and the portion near the open end of the drug sustained release cartridge 2 is inserted into the bulging portion 1a. The open end of the drug sustained release cartridge 2 faces the downstream end of the connection fitting 6.

【0012】本実施例に係る空調用クーリングタワーの
作動を説明する。本実施例に係る空調用クーリングタワ
ーにおいては、ビル等の空調に使用され温水化した冷却
水が、循環水配管4aを通って、クーリングタワー本体
3へ流入する。クーリングタワー本体3へ流入した温水
化した冷却水は、図示しない散水装置によって散水さ
れ、図示しない送風ファンから送風される空気流に接触
して、一部が蒸発する。散水された冷却水の残余の部分
から気化熱が奪われ、該残余の冷却水が冷却される。温
度が低下した冷却水は、クーリングタワー本体3の底部
に溜まる。クーリングタワー本体3の底部に溜まった低
温の冷却水は、ポンプ5によって吸引され、循環水配管
4bを通って、ビル等の内部へ還流する。温水化した冷
却水の一部がクーリングタワー本体3内で蒸発し大気中
へ放出されるので、時間の経過と共に、クーリングタワ
ー本体3の底部に溜まった低温の冷却水の水位が低下す
る。クーリングタワー本体3の底部に溜まった低温の冷
却水の水位が低下すると、図示しないフロート弁が水位
の低下を検知し、補給水用配水管1を通って水道水がク
ーリングタワー本体3へ供給される。補給水用配水管1
を水道水が流れると、膨出部1a内を流れる水道水の一
部が多孔質膜2aの中央部を通って薬剤徐放カートリッ
ジ2へ流入し、残余の部分は、薬剤徐放カートリッジ2
の周囲を流れ、膨出部1aの下流側の補給水用配水管1
へ流入する。
The operation of the air conditioning cooling tower according to this embodiment will be described. In the cooling tower for air conditioning according to the present embodiment, the cooling water that has been used for air conditioning of a building and the like and has been warmed flows into the cooling tower body 3 through the circulating water pipe 4a. The warmed cooling water that has flowed into the cooling tower body 3 is sprinkled by a sprinkler (not shown), comes into contact with an air flow blown by a blower fan (not shown), and a part thereof is evaporated. The heat of vaporization is taken from the remaining portion of the sprinkled cooling water, and the remaining cooling water is cooled. The cooling water having the lowered temperature collects at the bottom of the cooling tower body 3. The low-temperature cooling water accumulated at the bottom of the cooling tower body 3 is sucked by the pump 5 and flows back into the building or the like through the circulating water pipe 4b. Since a part of the heated cooling water is evaporated in the cooling tower body 3 and released into the atmosphere, the water level of the low-temperature cooling water accumulated at the bottom of the cooling tower body 3 decreases with the passage of time. When the water level of the low-temperature cooling water accumulated at the bottom of the cooling tower body 3 drops, a float valve (not shown) detects the water level drop, and tap water is supplied to the cooling tower body 3 through the makeup water distribution pipe 1. Makeup water distribution pipe 1
When the tap water flows through, the part of the tap water flowing in the bulging portion 1a flows into the drug sustained release cartridge 2 through the central portion of the porous membrane 2a, and the remaining part is the drug sustained release cartridge 2
Flow pipe 1 for make-up water flowing downstream of the bulging portion 1a
Flow into.

【0013】薬剤徐放カートリッジ2内へ流入した水道
水は、図2で破線の矢印で示すように、薬剤徐放カート
リッジ2の中心部を閉鎖端へ向かって進みつつ径方向へ
拡散し、流れの方向を変え、薬剤徐放カートリッジ2の
囲壁に沿う円筒状の流れとなって、薬剤徐放カートリッ
ジ2の開放端へ向かって進む。殺菌剤が水道水中に溶解
し、水道水は殺菌剤の飽和水溶液となる。殺菌剤の飽和
水溶液は、薬剤徐放カートリッジ2の開放端を覆う多孔
質膜2aの周縁から薬剤徐放カートリッジ2の外部へ流
出し、薬剤徐放カートリッジ2の周囲を流れる水道水に
混入する。殺菌剤の飽和水溶液が混入した水道水は、膨
出部1の下流の補給水用配水管1へ流入し、次いでクー
リングタワー本体3へ流入する。この結果、空調用冷却
水に定期的に殺菌剤が添加され、空調用冷却水が定期的
に殺菌される。
The tap water flowing into the drug sustained release cartridge 2 diffuses in the radial direction while advancing through the central portion of the drug sustained release cartridge 2 toward the closed end, as indicated by the broken line arrow in FIG. To change to a cylindrical flow along the surrounding wall of the drug sustained-release cartridge 2 and proceed toward the open end of the drug sustained-release cartridge 2. The disinfectant is dissolved in tap water, and the tap water becomes a saturated aqueous solution of the disinfectant. The saturated aqueous solution of the bactericide flows out of the drug sustained release cartridge 2 from the periphery of the porous membrane 2a covering the open end of the drug sustained release cartridge 2 and mixes with tap water flowing around the drug sustained release cartridge 2. Tap water mixed with a saturated aqueous solution of a bactericide flows into the makeup water distribution pipe 1 downstream of the bulging portion 1 and then into the cooling tower body 3. As a result, the sterilizing agent is added to the cooling water for air conditioning at regular intervals, and the cooling water for air conditioning is regularly sterilized.

【0014】薬剤徐放カートリッジ2の開放端が多孔質
膜2aによって覆われているので、膨出部1aを流れる
水道水の一部が徐々に薬剤徐放カートリッジ2内へ流入
する。この結果、薬剤徐放カートリッジ2内の水道水と
殺菌剤飽和水溶液の流れが安定する。薬剤徐放カートリ
ッジ2内には圧力変動によって体積が変化する空気が存
在しないので、薬剤徐放カートリッジ2内の水道水と殺
菌剤飽和水溶液の流れが安定する。薬剤徐放カートリッ
ジ2が硬質材で形成され内外圧差による変形を生じない
ので薬剤徐放カートリッジ2内の水道水と殺菌剤飽和水
溶液の流れが安定する。この結果、薬剤徐放カートリッ
ジ2内の殺菌剤飽和水溶液は、膨出部1aを流れる水道
水中に過剰放出されることなく安定して徐放される。薬
剤徐放カートリッジ2内の殺菌剤は安定して膨出部1a
を流れる水道水中に徐放されるので、本実施例に係る空
調用クーリングタワーを使用すれば、空調設備の循環ラ
インを長期に亘って殺菌できる。
Since the open end of the drug sustained release cartridge 2 is covered with the porous membrane 2a, a part of tap water flowing through the bulging portion 1a gradually flows into the drug sustained release cartridge 2. As a result, the flow of tap water and the bactericide saturated aqueous solution in the drug sustained release cartridge 2 is stabilized. Since there is no air whose volume changes due to pressure fluctuation in the drug sustained release cartridge 2, the flow of tap water and the bactericide saturated aqueous solution in the drug sustained release cartridge 2 becomes stable. Since the drug sustained-release cartridge 2 is made of a hard material and is not deformed due to the difference in internal and external pressures, the flow of tap water and the bactericide saturated aqueous solution in the drug sustained-release cartridge 2 is stable. As a result, the saturated aqueous bactericide solution in the drug sustained-release cartridge 2 is stably and slowly released without being excessively released into the tap water flowing through the bulging portion 1a. The bactericide in the drug sustained release cartridge 2 is stably bulged out 1a
Since the water is gradually released into the tap water flowing through, the circulation line of the air conditioning equipment can be sterilized for a long time by using the cooling tower for air conditioning according to the present embodiment.

【0015】接続金具6を回転させ、接続金具を軸線方
向へ移動させ、薬剤徐放カートリッジ2の開放端と接続
金具6の下流端との間の距離を調節して、多孔質膜2a
近傍の水圧分布を調節し、薬剤徐放カートリッジ2内へ
流入する水道水の量を調節できる。これにより、殺菌剤
飽和水溶液の徐放量を制御でき、殺菌剤が添加された水
道水の殺菌力を制御できる。薬剤徐放カートリッジ2
を、膨出部1aから所定距離引き出すと、薬剤徐放カー
トリッジ2によって押し開かれていた揺動蓋9が図2で
一点鎖線で示す位置まで揺動し、薬剤徐放カートリッジ
2の開放端を閉鎖する。従って、薬剤徐放カートリッジ
2を膨出部1aから所定距離引き出し、薬剤徐放カート
リッジ2の開放端を閉鎖して、殺菌剤が添加されていな
い水道水を補給水としてクーリングタワー本体3へ供給
することもできる。
The connecting member 6 is rotated to move the connecting member in the axial direction, and the distance between the open end of the drug sustained release cartridge 2 and the downstream end of the connecting member 6 is adjusted to adjust the porous membrane 2a.
By adjusting the water pressure distribution in the vicinity, the amount of tap water flowing into the drug sustained release cartridge 2 can be adjusted. This makes it possible to control the sustained release amount of the bactericide saturated aqueous solution and control the bactericidal power of tap water to which the bactericide is added. Drug sustained release cartridge 2
When is pulled out from the bulging portion 1a by a predetermined distance, the swing lid 9 pushed and opened by the medicine sustained-release cartridge 2 swings to the position shown by the alternate long and short dash line in FIG. Close. Therefore, the medicine sustained-release cartridge 2 is pulled out from the bulging portion 1a for a predetermined distance, the open end of the medicine sustained-release cartridge 2 is closed, and tap water containing no germicide is supplied to the cooling tower body 3 as makeup water. You can also

【0016】空調用クーリングタワーが使用され、膨出
部1aを水道水が流れている時は、膨出部1a内の水圧
により空気弁7、水抜弁8が閉鎖されている。空調用ク
ーリングタワーが不使用状態となって、膨出部1a内の
洗浄水の流れが停止すると、膨出部1a内の水圧が低下
し、空気弁7、水抜弁8が開放され、膨出部1a内の洗
浄水が水抜弁8を介して外部へ放出される。この結果、
空調用クーリングタワーが不使用状態にある時に、膨出
部1a内の残留水中に殺菌剤飽和水溶液が漏出し、薬剤
徐放カートリッジ2内の殺菌剤が早期に用尽される事態
の発生が防止される。
When a cooling tower for air conditioning is used and tap water is flowing through the bulging portion 1a, the air valve 7 and the drain valve 8 are closed by the water pressure in the bulging portion 1a. When the cooling tower for air conditioning is not used and the flow of washing water in the bulging portion 1a is stopped, the water pressure in the bulging portion 1a decreases, the air valve 7 and the drain valve 8 are opened, and the bulging portion is opened. The washing water in 1a is discharged to the outside through the drain valve 8. As a result,
When the cooling tower for air conditioning is not in use, it is possible to prevent the situation where the saturated aqueous solution of the sterilizing agent leaks into the residual water in the bulging portion 1a and the sterilizing agent in the drug sustained-release cartridge 2 is exhausted early. It

【0017】薬剤徐放カートリッジ2は、配水管1の膨
出部1aの外側に装着されているので、薬剤徐放カート
リッジ2の取り替え作業が容易である。
Since the drug sustained-release cartridge 2 is mounted on the outside of the bulging portion 1a of the water distribution pipe 1, the drug sustained-release cartridge 2 can be easily replaced.

【0018】図3に示す薬剤徐放カートリッジ付シャワ
ーヘッドを対象として、本発明で用いた薬剤徐放カート
リッジの薬剤徐放性能試験を行った。図3に示す薬剤徐
放カートリッジ付シャワーヘッドの構造を説明する。薬
剤徐放カートリッジ付シャワーヘッド21は、下流端に
多孔板から成る吐出口22aが形成され、上流端にねじ
部22bが形成され、内部に上流端から下流端に至る流
路22cが形成された筒体によって構成される第1部分
22と、下流端にねじ部23aが形成され、内部に上流
端から下流端に至る流路23bが形成された筒体によっ
て構成される第2部分23とを備えている。第2部分2
3の流路23bは、上流端から延びる小径部23b
1 と、小径部23b1 に接続し、下流端へ向かって漏斗
状に広がる拡径部23b2 とにより構成されている。第
2部分23には水抜弁24が取り付けられている。第2
部分23は、ねじ部23aが第1部分22のねじ部22
bに螺合した状態で、第1部分22に連結されている。
第2部分23の上流端は、給水ホース100に接続され
ている。
A drug sustained release performance test of the drug sustained release cartridge used in the present invention was conducted for the shower head with a drug sustained release cartridge shown in FIG. The structure of the shower head with the sustained drug release cartridge shown in FIG. 3 will be described. The shower head 21 with a sustained-release drug cartridge has a discharge port 22a formed of a perforated plate at the downstream end, a threaded portion 22b at the upstream end, and a channel 22c extending from the upstream end to the downstream end inside. A first portion 22 formed of a tubular body and a second portion 23 formed of a tubular body in which a threaded portion 23a is formed at the downstream end and a flow path 23b extending from the upstream end to the downstream end is formed inside. I have it. 2nd part 2
The flow passage 23b of No. 3 has a small diameter portion 23b extending from the upstream end.
1 and the enlarged diameter portion 23b 2 which is connected to the small diameter portion 23b 1 and expands in a funnel shape toward the downstream end. A drain valve 24 is attached to the second portion 23. Second
In the portion 23, the screw portion 23 a is the screw portion 22 of the first portion 22.
It is connected to the first portion 22 while being screwed into b.
The upstream end of the second portion 23 is connected to the water supply hose 100.

【0019】第1部分22の流路22c内に、薬剤徐放
カートリッジ25が挿入されている。薬剤徐放カートリ
ッジ25は、アクリル樹脂等の硬質材料から成る容器、
より詳しくは一端が閉鎖され他端が完全開放された直円
筒体25aと、直円筒体25aの開放端を覆う多孔質膜
25bとにより構成されている。直円筒体25aの外面
には、複数の突起25cが形成されている。薬剤徐放カ
ートリッジ25は、残留塩素除去機能を有するアスコル
ビン酸の粉末とアスコルビン酸飽和水溶液とによって満
たされており、薬剤徐放カートリッジ25内には圧縮性
の空気は存在しない。薬剤徐放カートリッジ25の製造
工程において、脱気した純水を用い、且つ、空気の混入
を防止しつつ直円筒体25aの開放端を多孔質膜25b
で覆うことにより、薬剤徐放カートリッジ25から空気
を完全に排除することができる。薬剤徐放カートリッジ
25は、多孔質膜25bによって覆われた開放端を上流
側へ向けて第2部分23の流路の拡径部23b2 内に位
置させ、突起25cを第1部分22を構成する筒体の内
面に当接させた状態で、第1部分22の流路22c内に
挿入されている。薬剤徐放カートリッジ25の周囲に、
環状流路22dが形成されている。
A drug sustained release cartridge 25 is inserted in the flow path 22c of the first portion 22. The drug sustained release cartridge 25 is a container made of a hard material such as acrylic resin,
More specifically, it is composed of a straight cylindrical body 25a having one end closed and the other end completely open, and a porous membrane 25b covering the open end of the straight cylindrical body 25a. A plurality of protrusions 25c are formed on the outer surface of the straight cylindrical body 25a. The drug sustained-release cartridge 25 is filled with powder of ascorbic acid having a residual chlorine removing function and a saturated aqueous solution of ascorbic acid, and there is no compressible air in the drug sustained-release cartridge 25. In the manufacturing process of the drug sustained release cartridge 25, deaerated pure water is used, and the open end of the right cylindrical body 25a is covered with a porous film 25b while preventing air from being mixed.
Air can be completely excluded from the drug sustained-release cartridge 25 by covering with. In the sustained drug release cartridge 25, the open end covered with the porous film 25b is located in the expanded portion 23b 2 of the flow path of the second portion 23 with the open end facing upstream, and the protrusion 25c constitutes the first portion 22. It is inserted into the flow path 22c of the first portion 22 while being in contact with the inner surface of the cylindrical body. Around the drug sustained release cartridge 25,
An annular flow path 22d is formed.

【0020】薬剤徐放カートリッジ付シャワーヘッド2
1の作動を説明する。給水ホース100から薬剤徐放カ
ートリッジ付シャワーヘッド21に水道水が供給され
る。図3で実線の矢印で示すように、第2部分23の流
路の拡径部23b2 を流れる水道水の一部は環状流路2
2dへ流入し、他の一部は、直円筒体25aの開放端の
中央部を通って薬剤徐放カートリッジ25内へ流入す
る。薬剤徐放カートリッジ25内へ流入した水道水は、
図3で破線の矢印で示すように、直円筒体25aの中心
部を閉鎖端へ向かって進みつつ径方向へ拡散し、流れの
方向を変え、直円筒体25aの囲壁に沿う円筒状の流れ
となって、直円筒体25aの開放端へ向かって進む。ア
スコルビン酸が水道水中に溶解し、水道水はアスコルビ
ン酸飽和水溶液となる。アスコルビン酸飽和水溶液は、
直円筒体25aの開放端の周縁から薬剤徐放カートリッ
ジ25の外部へ流出し、環状流路22dへ流入する水道
水に混入する。水道水に混入したアスコルビン酸によ
り、水道水中の残留塩素が除去される。塩素臭が除去さ
れた水道水が、シャワーヘッド21から吐出されること
により、シャワー利用者の快適感が増大する。
Shower head 2 with a drug sustained release cartridge
The operation of No. 1 will be described. Tap water is supplied from the water supply hose 100 to the shower head 21 with the medicine sustained release cartridge. As shown by the solid line arrow in FIG. 3, a part of the tap water flowing through the expanded diameter portion 23b 2 of the flow path of the second portion 23 is part of the annular flow path 2
2d, and the other part flows into the drug sustained release cartridge 25 through the central portion of the open end of the right cylindrical body 25a. The tap water flowing into the drug sustained release cartridge 25 is
As shown by the broken line arrow in FIG. 3, while advancing through the central portion of the straight cylindrical body 25a toward the closed end, it diffuses in the radial direction, changes the flow direction, and forms a cylindrical flow along the surrounding wall of the straight cylindrical body 25a. Thus, the straight cylinder 25a advances toward the open end. Ascorbic acid dissolves in tap water, and tap water becomes a saturated aqueous solution of ascorbic acid. Ascorbic acid saturated aqueous solution,
From the periphery of the open end of the straight cylindrical body 25a, it flows out to the outside of the drug sustained release cartridge 25 and mixes with the tap water flowing into the annular flow path 22d. Ascorbic acid mixed in tap water removes residual chlorine in tap water. By discharging the tap water from which the chlorine odor has been removed from the shower head 21, the comfort of the shower user is increased.

【0021】薬剤徐放カートリッジ付シャワーヘッド2
1においては、薬剤徐放カートリッジ25の開放端が多
孔質膜25bによって覆われているので、第2部分23
の流路の拡径部23b2 を流れる水道水の一部が徐々に
薬剤徐放カートリッジ25内へ流入する。この結果、薬
剤徐放カートリッジ25内の水道水とアスコルビン酸飽
和水溶液の流れが安定する。薬剤徐放カートリッジ25
内には圧力変動によって体積が変化する空気が存在しな
いので、薬剤徐放カートリッジ25内の水道水とアスコ
ルビン酸飽和水溶液の流れが安定する。薬剤徐放カート
リッジ25が硬質材で形成され内外圧差による変形を生
じないので薬剤徐放カートリッジ25内の水道水とアス
コルビン酸飽和水溶液の流れが安定する。この結果、薬
剤徐放カートリッジ25内のアスコルビン酸飽和水溶液
は、シャワーの使用中に過剰放出されることなく、環状
流路22dへ流入する水道水中に安定して徐放される。
Shower head 2 with sustained drug release cartridge
In No. 1, since the open end of the drug sustained release cartridge 25 is covered with the porous film 25b, the second portion 23
A part of the tap water flowing through the enlarged diameter portion 23b 2 of the channel gradually flows into the drug sustained release cartridge 25. As a result, the flow of tap water and the saturated ascorbic acid aqueous solution in the drug sustained release cartridge 25 is stabilized. Drug sustained release cartridge 25
Since there is no air whose volume changes due to pressure fluctuation, the flow of tap water and saturated ascorbic acid aqueous solution in the drug sustained release cartridge 25 is stabilized. Since the drug sustained-release cartridge 25 is made of a hard material and is not deformed due to an internal / external pressure difference, the flow of tap water and the saturated ascorbic acid aqueous solution in the drug sustained-release cartridge 25 is stable. As a result, the saturated ascorbic acid aqueous solution in the drug sustained-release cartridge 25 is stably released into the tap water flowing into the annular flow path 22d without being excessively released during the use of the shower.

【0022】薬剤徐放カートリッジ25は一端が閉鎖さ
れ他端が開放された筒体なので、薬剤徐放カートリッジ
付シャワーヘッド21の流路22c内に容易に挿入でき
る。薬剤徐放カートリッジ付シャワーヘッド21におい
ては、薬剤徐放カートリッジ25がシャワーヘッド21
の流路22c内に配設されているので、薬剤徐放カート
リッジ25がシャワーヘッド21によって保護され、外
力によって薬剤徐放カートリッジ25が破損する等の事
故の発生が防止される。
Since the sustained drug release cartridge 25 is a cylindrical body having one end closed and the other end open, it can be easily inserted into the flow path 22c of the shower head 21 with a sustained drug release cartridge. In the shower head 21 with the drug sustained release cartridge, the drug sustained release cartridge 25 is the shower head 21.
Since it is provided in the flow path 22c, the medicine sustained release cartridge 25 is protected by the shower head 21 and an accident such as damage of the medicine sustained release cartridge 25 due to an external force is prevented.

【0023】薬剤徐放カートリッジ付シャワーヘッド2
1においては、薬剤徐放カートリッジ25の開放端の開
口面積が十分に大きいので、前記開口中の流路23b2
から薬剤徐放カートリッジ25内へ流入する水が通過す
る部分と、薬剤徐放カートリッジ25から流路23b2
へ放出されるアスコルビン酸飽和水溶液が通過する部分
とが、重ならない。この結果、薬剤徐放カートリッジ2
5内の液体の流れが安定し、薬剤徐放カートリッジ25
内のアスコルビン酸飽和水溶液が安定して徐放される。
Shower head 2 with sustained drug release cartridge
In No. 1, since the opening area of the open end of the drug sustained release cartridge 25 is sufficiently large, the flow path 23b 2 in the opening is large.
A portion of water passes flowing into sustained drug release cartridge 25 from, the drug sustained-release cartridge 25 from the flow path 23b 2
The part where the saturated aqueous solution of ascorbic acid released to the passage does not overlap. As a result, the drug sustained release cartridge 2
The liquid flow in 5 is stable, and the drug sustained release cartridge 25
The saturated aqueous solution of ascorbic acid therein is released slowly and stably.

【0024】薬剤徐放カートリッジ付シャワーヘッド2
1においては、第1部分22と第2部分23との螺合角
度を調節することにより、小径流路23b1 の下流端と
薬剤徐放カートリッジ25の開放端との間の距離を調節
し、多孔質膜25b近傍の水圧分布を調節し、薬剤徐放
カートリッジ25内へ流入する水道水の量を調節でき
る。これにより、アスコルビン酸飽和水溶液の徐放量を
制御できる。環状流路22dへ流入する水道水は、拡径
流路23b2 の囲壁に沿ってスムーズに流れるので、薬
剤徐放カートリッジ25の開放端近傍で、水道水の流れ
が乱れるおそれは無い。この結果、薬剤徐放カートリッ
ジ25内のアスコルビン酸飽和水溶液が安定して徐放さ
れる。
Shower head 2 with a drug sustained release cartridge
In No. 1, by adjusting the screwing angle between the first portion 22 and the second portion 23, the distance between the downstream end of the small diameter passage 23b 1 and the open end of the drug sustained release cartridge 25 is adjusted, By adjusting the water pressure distribution in the vicinity of the porous film 25b, the amount of tap water flowing into the drug sustained release cartridge 25 can be adjusted. Thereby, the sustained release amount of the saturated ascorbic acid aqueous solution can be controlled. The tap water flowing into the annular flow path 22d smoothly flows along the surrounding wall of the diameter-expanding flow path 23b 2 , so that the flow of tap water is not disturbed near the open end of the sustained drug release cartridge 25. As a result, the saturated ascorbic acid aqueous solution in the drug sustained-release cartridge 25 is stably and slowly released.

【0025】薬剤徐放カートリッジ付シャワーヘッド2
1においては、シャワー使用中はシャワーヘッド内の水
圧により閉鎖される構造の水抜き弁24がシャワー使用
後に開放され、水抜き弁24を介して、流路22c、2
2d、23b2 、23b1 内の水を、外部へ放出するこ
とができる。この結果、シャワー不使用中にシャワーヘ
ッド21内の残留水中にアスコルビン酸が溶出し、薬剤
徐放カートリッジ25内のアスコルビン酸が早期に用尽
される事態の発生が防止される。
Shower head 2 with sustained drug release cartridge
1, the water drain valve 24, which is closed by the water pressure in the shower head during use of the shower, is opened after the shower is used, and the flow channels 22c, 2
The water in 2d, 23b 2 and 23b 1 can be discharged to the outside. As a result, it is possible to prevent the situation where ascorbic acid is eluted into the residual water in the shower head 21 when the shower is not used and the ascorbic acid in the drug sustained release cartridge 25 is exhausted early.

【0026】差分法による汎用流体解析プログラムを用
い、下記の条件で、シャワーヘッド内の流体の流動解析
を行った。 流体 : H2O (密度ρ=992.3 Kg/m3、動粘性係数ν=
0.667×10-6 m2/sec) 流量 : 0.167 ×10 -3 m3/sec 多孔質膜による抵抗 : 5.5 ×10 -3 m/sec (at △
p=9.8×102 Pa) 解析条件 : No slip 条件 薬剤徐放カートリッジ外径 : 18mm 薬剤徐放カートリッジ内径 : 16mm 薬剤徐放カートリッジ長 : 100mm シャワーヘッド内径 : 22mm シャワーヘッド長 : 300mm 薬剤徐放カートリッジの配設位置 : シャワーヘッド
の長さ方向の中央部に、シャワーヘッドに同軸に、開放
端を上流側ヘ向けて配置した。
Using a general-purpose fluid analysis program by the difference method, the fluid flow in the shower head was analyzed under the following conditions. Fluid: H 2 O (density ρ = 992.3 Kg / m 3 , kinematic viscosity coefficient ν =
0.667 × 10 -6 m 2 / sec) Flow rate: 0.167 × 10 -3 m 3 / sec Resistance due to porous membrane: 5.5 × 10 -3 m / sec (at △
p = 9.8 × 10 2 Pa) Analysis condition: No slip condition Drug sustained release cartridge outer diameter: 18mm Drug sustained release cartridge inner diameter: 16mm Drug sustained release cartridge length: 100mm Shower head inner diameter: 22mm Shower head length: 300mm Drug sustained release cartridge Arrangement position: The open end was arranged at the central portion in the length direction of the shower head, coaxially with the shower head, with the open end facing the upstream side.

【0027】解析によって得られた、通水開始20秒後
の薬剤徐放カートリッジの開放端近傍の流体の水圧分布
の等高線と速度ベクトルの分布とを図4に示す。図4か
ら、薬剤徐放カートリッジの開放端の中央部では多孔質
膜の外面に加わる水圧が多孔質膜の内面に加わる水圧、
すなわち薬剤徐放カートリッジ内部の水圧よりも大き
く、他方、薬剤徐放カートリッジの開放端の周縁部では
多孔質膜の外面に加わる水圧が多孔質膜の内面に加わる
水圧よりも小さく、この結果、薬剤徐放カートリッジの
開放端の中央部ではシャワーヘッドの流路から薬剤徐放
カートリッジ内へ水が流入し、薬剤徐放カートリッジの
開放端の周縁部では薬剤徐放カートリッジからシャワー
ヘッドの流路ヘ水が流出する事が確認される。
FIG. 4 shows the contour lines and the velocity vector distribution of the hydraulic pressure distribution of the fluid in the vicinity of the open end of the drug sustained release cartridge 20 seconds after the start of water flow obtained by the analysis. From FIG. 4, in the central portion of the open end of the drug sustained release cartridge, the water pressure applied to the outer surface of the porous membrane is the water pressure applied to the inner surface of the porous membrane,
That is, the water pressure applied to the outer surface of the porous membrane is smaller than the water pressure applied to the inner surface of the porous membrane at the peripheral portion of the open end of the drug sustained release cartridge. At the center of the open end of the sustained-release cartridge, water flows from the showerhead channel into the drug sustained-release cartridge, and at the peripheral edge of the open-end of the sustained-release cartridge, water flows from the sustained-release cartridge to the showerhead channel. Is confirmed to be leaked.

【0028】薬剤徐放カートリッジの多孔質膜の内表面
から薬剤徐放カートリッジ内部へ2mm離れた位置で、
且つ薬剤徐放カートリッジの中心線から径方向に0.2
5mm離れた位置(A)、2.75mm離れた位置
(B)、5.25mm離れた位置(C)、7.75mm
離れた位置(D)における、流体の軸方向の速度成分
(下流へ向かう方向を正、上流へ向かう方向を負とす
る)の経時変化を図5に示す。図5から、薬剤徐放カー
トリッジ内へ流入する水の流れと薬剤徐放カートリッジ
から流出する水の流れとが、流水開始後短時間内に定常
状態に達すること、すなわち、薬剤徐放カートリッジか
ら薬剤が安定して徐放されることが確認される。
At a position 2 mm away from the inner surface of the porous membrane of the drug sustained release cartridge to the inside of the drug sustained release cartridge,
And 0.2 in the radial direction from the center line of the drug sustained release cartridge.
Position 5 mm apart (A), position 2.75 mm apart (B), position 5.25 mm apart (C), 7.75 mm
FIG. 5 shows the change over time in the axial velocity component of the fluid (the downstream direction is positive and the upstream direction is negative) at the distant position (D). From FIG. 5, it can be seen that the flow of water flowing into the drug sustained release cartridge and the flow of water flowing out of the drug sustained release cartridge reach a steady state within a short time after the start of water flow, that is, from the drug sustained release cartridge. Is confirmed to be stable and sustained release.

【0029】図3に示す薬剤徐放カートリッジ付シャワ
ーヘッド21を用いて、水道水中の残留塩素除去能力の
測定実験を行った。薬剤徐放カートリッジ付シャワーヘ
ッド21の把持部の内径、すなわち環状流路22dの外
径を24mmとし、薬剤徐放カートリッジ25を構成す
る直円筒体25aの外径×内径×長さを20mm×16
mm×120mmとした。直円筒体25aの開放端を覆
う多孔質膜25bとして、ポリエステル繊維をセルロー
スアセテート樹脂で被覆した細孔径が10μmの多孔質
膜を、公称繊維径2μm、公称細孔径4.3〜4.7μ
mの極細ポリエステル繊維の織布でサンドイッチしたも
のを用いた。薬剤徐放カートリッジ25内に、アスコル
ビン酸粉末20gを充填し、更に脱気した純水を満たし
て、薬剤徐放カートリッジ25から空気を完全に排除し
た。薬剤徐放カートリッジ付シャワーヘッド21に、残
留塩素を1.5mg/dm3 以上の濃度で含有する40
℃の水道水を、通水流量10dm3 /分、通水時の水圧
0.4kgf/cm2 で、1日に付き20分すなわち2
00dm3 通水した。通水停止後、水抜き弁4を介して
シャワーヘッド21内の残留水を放出し、24時間以上
放置した。以後、上記の通水と、残留水の放出と、放置
とを繰り返した。20分の通水中、通水開始後1分、5
分、10分、20分の時点で、薬剤徐放カートリッジ付
シャワーヘッド21の残留塩素除去能力(薬剤徐放カー
トリッジ付シャワーヘッド21に供給される水道水の残
留塩素濃度と、薬剤徐放カートリッジ付シャワーヘッド
21から吐出される水の残留塩素濃度との差)を測定し
た。計測結果を、図6に示す。図6から、略1mg/d
3 の残留塩素除去能力が各通水中に安定して維持さ
れ、且つ、長期に亘って安定して維持されていることが
分かる。
An experiment for measuring the residual chlorine removing ability in tap water was conducted by using the shower head 21 with a drug sustained release cartridge shown in FIG. The inner diameter of the grip portion of the shower head 21 with a sustained drug release cartridge, that is, the outer diameter of the annular flow path 22d is set to 24 mm, and the outer diameter × inner diameter × length of the right cylindrical body 25a constituting the sustained drug release cartridge 25 is 20 mm × 16.
It was set to mm × 120 mm. As the porous membrane 25b covering the open end of the right cylindrical body 25a, a porous membrane having a pore diameter of 10 μm, which is obtained by coating polyester fiber with a cellulose acetate resin, is used, which has a nominal fiber diameter of 2 μm and a nominal pore diameter of 4.3 to 4.7 μm.
Sandwiched with a woven fabric of m ultrafine polyester fibers was used. The drug sustained-release cartridge 25 was filled with 20 g of ascorbic acid powder and filled with deaerated pure water to completely remove air from the drug sustained-release cartridge 25. The shower head 21 with a drug sustained release cartridge contains residual chlorine at a concentration of 1.5 mg / dm 3 or more.
C. Tap water at a flow rate of 10 dm 3 / min and a water pressure of 0.4 kgf / cm 2 at the time of passing 20 minutes per day, that is, 2
00 dm 3 water was passed. After the water flow was stopped, residual water in the shower head 21 was discharged through the water drain valve 4 and left for 24 hours or more. After that, the above-mentioned water flow, release of residual water, and standing were repeated. Water flow for 20 minutes, 1 minute after the start of water flow, 5
At 10 minutes, 10 minutes and 20 minutes, the residual chlorine removing ability of the shower head 21 with a sustained-release medicine cartridge (the residual chlorine concentration of tap water supplied to the shower head 21 with a sustained-release medicine cartridge and the sustained-release cartridge with a sustained-release cartridge) The difference from the residual chlorine concentration of the water discharged from the shower head 21) was measured. The measurement result is shown in FIG. From FIG. 6, approximately 1 mg / d
It can be seen that the residual chlorine removal capacity of m 3 is stably maintained in each of the water passages and is also stably maintained for a long period of time.

【0030】流入口と流出口とを有するアスコルビン酸
が充填された薬剤徐放カートリッジが、シャワーヘッド
に装着され、薬剤徐放カートリッジの流入口と流出口と
が、シャワーヘッド内部の流路に連通している、特開平
6−296902号の図2に相当する市販の薬剤徐放機
能付シャワーヘッドを用いて、水道水中の残留塩素除去
能力の測定実験を行った。薬剤徐放機能付シャワーヘッ
ドに、残留塩素を1.5mg/dm3 以上の濃度で含有
する40℃の水道水を、通水流量10dm3 /分、通水
時の水圧0.4kgf/cm2 で、1日に付き20分す
なわち200dm3 通水した。通水停止後、24時間以
上放置した。以後、上記の通水と、放置とを繰り返し
た。20分の通水中、通水開始後5分、10分、20分
の時点で、薬剤徐放機能付シャワーヘッドの残留塩素除
去能力を測定した。計測結果を、図7に示す。図7か
ら、特開平6−296902号の図2に相当する市販の
薬剤徐放機能付シャワーヘッドでは、各通水において、
通水開始直後にはアスコルビン酸が過剰に溶出し、通水
時間の経過と共に、アスコルビン酸の溶出量が急激に減
少していること、すなわち、安定したアスコルビン酸の
徐放が期待できないことが分かる。上記市販の薬剤徐放
機能付シャワーヘッドでは、アスコルビン酸が過剰に溶
出するので、薬剤徐放カートリッジ内のアスコルビン酸
の消耗が激しく、薬剤徐放カートリッジの寿命が短い。
A drug sustained-release cartridge filled with ascorbic acid having an inflow port and an outflow port is mounted on a showerhead, and the inflow port and the outflow port of the drug sustained-release cartridge communicate with a flow path inside the showerhead. Using the commercially available shower head with sustained drug release function corresponding to FIG. 2 of JP-A-6-296902, a measurement experiment of residual chlorine removal ability in tap water was conducted. In the shower head with a sustained chemical release function, tap water containing residual chlorine at a concentration of 1.5 mg / dm 3 or more at 40 ° C was used, and the water flow rate was 10 dm 3 / min, and the water pressure during water flow was 0.4 kgf / cm 2. Then, 20 minutes per day, that is, 200 dm 3 of water was passed. After the water flow was stopped, it was left for 24 hours or more. After that, the above water flow and standing were repeated. The residual chlorine removing ability of the shower head with the sustained drug release function was measured at the time of 5 minutes, 10 minutes, and 20 minutes after the start of water passage in water passage for 20 minutes. The measurement result is shown in FIG. From FIG. 7, in the commercially available shower head with a sustained drug release function corresponding to FIG. 2 of JP-A-6-296902, in each water passage,
Ascorbic acid was excessively eluted immediately after the start of water flow, and the amount of ascorbic acid eluted was drastically decreased with the passage of water, that is, stable sustained release of ascorbic acid cannot be expected. . In the commercially available showerhead with a sustained drug release function, ascorbic acid is excessively eluted, so that the ascorbic acid in the sustained drug release cartridge is heavily consumed, and the life of the sustained drug release cartridge is short.

【0031】図3の薬剤徐放カートリッジ付シャワーヘ
ッド21を用い、水道水中の残留塩素除去能力の測定実
験を行った。薬剤徐放カートリッジ付シャワーヘッド2
1の把持部の内径、すなわち環状流路22dの外径を2
4mmとし、薬剤徐放カートリッジ25を構成する直円
筒体5aの外径×内径×長さを20mm×16mm×1
20mmとした。図8(a)、(c)、(d)に示すよ
うに、直円筒体25aの開放端の、直円筒体25aの軸
線に対する角度を種々に変えて、該角度が薬剤徐放カー
トリッジ付シャワーヘッド21の残留塩素除去能力に及
ぼす影響を調べた。また、図8(b)に示すように、直
円筒体25aの開放端を下流側へ向けた場合、図8
(e)に示すように、直円筒体25aの両端を閉鎖し、
延在方向の中央部に開口を設けた場合についても、水道
水中の残留塩素除去能力の測定実験を行った。図8
(a)〜(d)において、直円筒体25aの開放端を覆
う多孔質膜25bとして、公称繊維径2μm、公称細孔
径4.3〜4.7μmの極細ポリエステル繊維の織布を
用いた。図8(e)の開口も、公称繊維径2μm、公称
細孔径4.3〜4.7μmの極細ポリエステル繊維の織
布で覆った。薬剤徐放カートリッジ付シャワーヘッド2
1に、残留塩素を1.5mg/dm3 以上の濃度で含有
する10℃〜14℃の水道水を、通水時の水圧0.4k
gf/cm2 で、通水流量を種々に変えて通水し、薬剤
徐放カートリッジ付シャワーヘッド21の残留塩素除去
能力を測定した。
An experiment for measuring the residual chlorine removal ability in tap water was conducted using the shower head 21 with a sustained drug release cartridge shown in FIG. Shower head with sustained release cartridge 2
The inner diameter of the gripping portion of 1, that is, the outer diameter of the annular flow path 22d is 2
4 mm, and the outer diameter × inner diameter × length of the right cylindrical body 5a constituting the drug sustained release cartridge 25 is 20 mm × 16 mm × 1.
It was set to 20 mm. As shown in FIGS. 8 (a), (c), and (d), the angle of the open end of the straight cylindrical body 25a with respect to the axis of the straight cylindrical body 25a is variously changed, and the angle is a shower with a drug sustained release cartridge. The effect of the head 21 on the residual chlorine removing ability was examined. Further, as shown in FIG. 8B, when the open end of the straight cylindrical body 25a is directed to the downstream side, as shown in FIG.
As shown in (e), both ends of the right cylindrical body 25a are closed,
A measurement experiment of residual chlorine removal ability in tap water was also conducted when an opening was provided at the center in the extending direction. FIG.
In (a) to (d), a woven fabric of ultrafine polyester fibers having a nominal fiber diameter of 2 μm and a nominal pore diameter of 4.3 to 4.7 μm was used as the porous membrane 25b covering the open end of the right cylindrical body 25a. The opening in FIG. 8 (e) was also covered with a woven fabric of ultrafine polyester fibers having a nominal fiber diameter of 2 μm and a nominal pore diameter of 4.3 to 4.7 μm. Shower head with sustained release cartridge 2
1, tap water of 10 ° C to 14 ° C containing residual chlorine at a concentration of 1.5 mg / dm 3 or more, and a water pressure of 0.4 k when passing water
Water was passed through gf / cm 2 at various flow rates, and the residual chlorine removing ability of the shower head 21 with the sustained-release cartridge for chemicals was measured.

【0032】計測結果を、図9に示す。図9から、直円
筒体25aの開放端の、直円筒体25aの軸線に対する
角度が45°の場合、60°の場合、90°の場合に
は、吐水流量の増大に伴って、薬剤徐放カートリッジ付
シャワーヘッド21の残留塩素除去能力が増大するこ
と、すなわち、吐出水中のアスコルビン酸濃度が増大す
ることが分かる。他方、直円筒体25aの開放端を下流
側へ向けた場合には、アスコルビン酸が吐水中に殆ど溶
出しないことが分かる。また、直円筒体25aの両端を
閉鎖し、延在方向の中央部に開口を設けた場合には、吐
水流量の増大に伴って吐出水中のアスコルビン酸濃度が
増大するが、吐水流量が8dm3 /分を越えると、吐水
流量の増大に伴って吐出水中のアスコルビン酸濃度が減
少することが分かる。図9から判断して、直円筒体25
aの開放端が上流側へ差し向けられ、直円筒体25aの
開放端の、直円筒体25aの軸線に対する角度が30°
〜90°であれば、シャワーの吐出流量の増大に伴っ
て、直円筒体25aからのアスコルビン酸の徐放量は増
大し、吐出水中のアスコルビン酸濃度は増大するものと
考えられる。すなわち、直円筒体25aの開放端を上流
側へ差し向け、直円筒体25aの開放端の、直円筒体2
5aの軸線に対する角度を30°〜90°に設定するこ
とにより、一般に快適な吐出流量とされる8dm3 /分
〜12dm3 /分の範囲で、吐出水中のアスコルビン酸
濃度が低下し、塩素臭のある水がシャワーヘッドから吐
出する事態の発生が防止されると考えられる。
The measurement results are shown in FIG. From FIG. 9, when the angle of the open end of the straight cylindrical body 25a with respect to the axis of the straight cylindrical body 25a is 45 °, 60 °, or 90 °, the drug is gradually released as the discharge flow rate increases. It can be seen that the residual chlorine removing ability of the shower head 21 with a cartridge increases, that is, the concentration of ascorbic acid in the discharged water increases. On the other hand, when the open end of the straight cylindrical body 25a is directed to the downstream side, it is found that ascorbic acid hardly elutes in the discharged water. When both ends of the straight cylindrical body 25a are closed and an opening is provided at the central portion in the extending direction, the ascorbic acid concentration in the discharged water increases as the discharge water flow rate increases, but the discharge water flow rate is 8 dm 3. It can be seen that when the flow rate exceeds / minute, the ascorbic acid concentration in the discharged water decreases with an increase in the discharged water flow rate. Judging from FIG. 9, the right cylindrical body 25
The open end of a is directed to the upstream side, and the angle of the open end of the straight cylindrical body 25a with respect to the axis of the straight cylindrical body 25a is 30 °.
If it is ˜90 °, it is considered that the sustained release amount of ascorbic acid from the straight cylindrical body 25a increases and the ascorbic acid concentration in the discharged water increases as the shower discharge flow rate increases. That is, the open end of the straight cylindrical body 25a is directed to the upstream side, and the open end of the straight cylindrical body 25a is connected to the straight cylindrical body 2a.
By setting the angle to the axis of 5a in 30 ° to 90 °, typically in a comfortable range of 8dm 3 / min ~12dm 3 / min, which is a discharge flow rate, ascorbic acid concentration in the discharge water is reduced, chlorine odor It is considered that the occurrence of the situation where some water is discharged from the shower head is prevented.

【0033】以上本発明の実施例を説明したが、本発明
は上記実施例に限定されない。図1、3の実施例におい
て、膨出部1aの外側に薬剤徐放カートリッジ2を装着
するのに代えて、図3の薬剤徐放カートリッジ付シャワ
ーヘッド21と同様に、膨出部1a内に薬剤徐放カート
リッジ2を配設しても良い。膨出部1aによって薬剤徐
放カートリッジ2が保護され、薬剤徐放カートリッジ2
が外力によって破損する等の事故の発生が防止される。
なお、薬剤徐放カートリッジ2の取り替え作業を容易に
するために、膨出部1aに蓋部材を取付るのが望まし
い。
Although the embodiments of the present invention have been described above, the present invention is not limited to the above embodiments. In the embodiment of FIGS. 1 and 3, instead of mounting the drug sustained release cartridge 2 on the outer side of the bulging portion 1a, as in the shower head 21 with a drug sustained release cartridge of FIG. The drug sustained release cartridge 2 may be provided. The swollen portion 1a protects the drug sustained release cartridge 2 and
The occurrence of accidents such as damage to the product due to external force is prevented.
In order to facilitate the replacement work of the drug sustained release cartridge 2, it is desirable to attach a lid member to the bulging portion 1a.

【0034】図1、3の実施例において、空気弁7、水
抜弁8を廃止し、空調用クーリングタワーの不使用時
に、薬剤徐放カートリッジ2を膨出部1aから所定距離
引き出し、薬剤徐放カートリッジ2の開放端を閉鎖し
て、殺菌剤の漏出を防止しても良い。
In the embodiment shown in FIGS. 1 and 3, the air valve 7 and the water drain valve 8 are eliminated, and when the air-conditioning cooling tower is not used, the drug sustained release cartridge 2 is pulled out from the bulging portion 1a by a predetermined distance, and the drug sustained release cartridge is pulled out. The open end of 2 may be closed to prevent leakage of the germicide.

【0035】薬剤徐放カートリッジ2に充填する殺菌剤
は、水溶性の液体でも良く、水溶性の固体でも良い。
The bactericide to be filled in the drug sustained release cartridge 2 may be a water-soluble liquid or a water-soluble solid.

【0036】多孔質膜2a、25bの膜面積、孔径、膜
厚、材質、孔密度等を適宜選択することにより、殺菌剤
の種類、補給水用配水管内の水道水の流量等に応じて、
殺菌剤徐放量を所望の値に調整し、水道水中の殺菌剤濃
度を所望の値に調整できる。
By appropriately selecting the membrane area, pore diameter, film thickness, material, pore density and the like of the porous membranes 2a and 25b, depending on the type of sterilizing agent, the flow rate of tap water in the distribution pipe for makeup water, etc.
The bactericide sustained release amount can be adjusted to a desired value, and the bactericide concentration in tap water can be adjusted to a desired value.

【0037】[0037]

【発明の効果】本発明に係る空調用クーリングタワーに
おいては、補給水用配水管を通って水道水がクーリング
タワーへ供給される際に、補給水用配水管を流れる水道
水の一部が、薬剤徐放カートリッジに形成された単一の
開口を通って、薬剤徐放カートリッジ内に洗浄水が侵入
し、薬剤徐放カートリッジ内の水溶性の液状の殺菌剤又
は水溶性の殺菌剤の飽和水溶液が、前記単一の開口を通
って、配水管を流れる水道水中へ放出される。薬剤徐放
カートリッジの開口は多孔質膜によって覆われており、
薬剤徐放カートリッジ内には圧力変動によって体積が変
化する空気が存在せず、薬剤徐放カートリッジは硬質材
で形成され外圧を加えても変形しないので、薬剤徐放カ
ートリッジ内の水溶性の液状の殺菌剤又は水溶性の殺菌
剤の飽和水溶液は、過剰放出されることなく安定して補
給水用配水管を流れる水道水中に徐放される。殺菌剤が
添加された水道水は補給水用配水管を通って空調用クー
リングタワーへ流入する。この結果、空調用冷却水に定
期的に殺菌剤が添加され、空調用冷却水が定期的に殺菌
される。水溶性の液状の殺菌剤又は水溶性の殺菌剤の飽
和水溶液は安定して補給水用配水管を流れる水道水中に
徐放されるので、本発明に係る空調用クーリングタワー
を使用すれば、空調設備の循環ラインを長期に亘って殺
菌できる。
In the cooling tower for air conditioning according to the present invention, when the tap water is supplied to the cooling tower through the distribution pipe for makeup water, a part of the tap water flowing through the distribution pipe for makeup water is treated with the chemical suspension. Wash water enters the drug sustained-release cartridge through a single opening formed in the drug-release cartridge, and the water-soluble liquid bactericide or saturated aqueous solution of the water-soluble bactericide in the drug sustained-release cartridge, Through the single opening, it is discharged into tap water flowing through a water pipe. The opening of the drug sustained release cartridge is covered with a porous film,
Since there is no air whose volume changes due to pressure fluctuations in the drug sustained-release cartridge, and the drug sustained-release cartridge is formed of a hard material and does not deform even when external pressure is applied, the drug sustained-release cartridge contains a water-soluble liquid. The bactericidal agent or a saturated aqueous solution of a water-soluble bactericidal agent is stably released into the tap water flowing through the makeup water distribution pipe without being released excessively. The tap water to which the bactericide is added flows into the cooling tower for air conditioning through the distribution pipe for makeup water. As a result, the sterilizing agent is added to the cooling water for air conditioning at regular intervals, and the cooling water for air conditioning is regularly sterilized. Since a water-soluble liquid germicide or a saturated aqueous solution of a water-soluble germicide is stably released into tap water flowing through a distribution pipe for makeup water, if an air conditioning cooling tower according to the present invention is used, The circulation line can be sterilized for a long time.

【0038】薬剤徐放カートリッジを補給水用配水管の
外側に装着することにより、薬剤徐放カートリッジの交
換が容易になる。
By mounting the drug sustained release cartridge on the outside of the makeup water distribution pipe, the drug sustained release cartridge can be easily replaced.

【0039】一端が閉鎖され他端が開放された筒体から
成る薬剤徐放カートリッジを補給水用配水管内に配設
し、薬剤徐放カートリッジと補給水用配水管の囲壁との
間に隙間を形成することにより、薬剤徐放カートリッジ
が補給水用配水管によって保護され、外力によって薬剤
徐放カートリッジが破損する等の事故の発生が防止され
る。
A medicine sustained-release cartridge, which is a cylindrical body having one end closed and the other end open, is arranged in the makeup water distribution pipe, and a gap is provided between the medicine sustained-release cartridge and the surrounding wall of the makeup water distribution pipe. By forming it, the medicine sustained-release cartridge is protected by the makeup water distribution pipe, and an accident such as damage to the medicine sustained-release cartridge due to external force is prevented.

【0040】補給水用配水管から薬剤徐放カートリッジ
へ流入する水量を調節する水量調節装置を配設すること
により、殺菌剤の徐放量の調節が可能となる。
By disposing a water amount adjusting device for adjusting the amount of water flowing into the medicine sustained-release cartridge from the makeup water distribution pipe, the sustained-release amount of the bactericide can be adjusted.

【0041】空調用クーリングタワーの停止時に薬剤徐
放カートリッジから殺菌剤が漏出するのを防止する殺菌
剤漏出防止装置を配設することにより、空調用クーリン
グタワーの停止時に補給水用配水管内の残留水中に殺菌
剤が漏出し、早期に殺菌剤が用尽される事態の発生が防
止される。
By disposing a disinfectant leakage preventive device for preventing the disinfectant from leaking out from the drug sustained-release cartridge when the cooling tower for air conditioning is stopped, when the cooling tower for air conditioning is stopped, residual water in the distribution pipe for makeup water It is possible to prevent the situation where the disinfectant leaks out and the disinfectant is exhausted early.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の実施例に係る空調用クーリングタワー
の構成図である。
FIG. 1 is a configuration diagram of an air conditioning cooling tower according to an embodiment of the present invention.

【図2】本発明の実施例に係る空調用クーリングタワー
の薬剤徐放カートリッジの取付状態を示す、前記取付部
近傍の断面図である。
FIG. 2 is a cross-sectional view of the vicinity of the mounting portion, showing the mounting state of the drug sustained release cartridge of the cooling tower for air conditioning according to the embodiment of the present invention.

【図3】薬剤徐放カートリッジの性能試験の対象とした
薬剤徐放カートリッジ付シャワーヘッドの断面図であ
る。
FIG. 3 is a cross-sectional view of a shower head with a drug sustained release cartridge, which is a target of a performance test of the drug sustained release cartridge.

【図4】差分法による汎用流体解析プログラムを用いた
シャワーヘッド内の流体の流動解析によって得られた、
薬剤徐放カートリッジの開放端近傍の流体の圧力分布と
流速分布とを示す図である。
FIG. 4 is obtained by a flow analysis of a fluid in a shower head using a general-purpose fluid analysis program by the difference method,
FIG. 6 is a diagram showing a pressure distribution and a flow velocity distribution of a fluid near the open end of the drug sustained release cartridge.

【図5】差分法による汎用流体解析プログラムを用いた
シャワーヘッド内の流体の流動解析によって得られた、
薬剤徐放カートリッジの開放端での複数の径方向位置に
おける流体の速度の経時変化を示す図である。
FIG. 5 is obtained by a flow analysis of a fluid in a shower head using a general-purpose fluid analysis program by the difference method,
It is a figure which shows the time-dependent change of the velocity of the fluid in the some radial direction position in the open end of a medicine sustained release cartridge.

【図6】図3の薬剤徐放カートリッジ付シャワーヘッド
の残留塩素除去能力を示す図である。
FIG. 6 is a diagram showing the residual chlorine removal capability of the shower head with a sustained-release drug cartridge of FIG.

【図7】従来技術に係る薬剤徐放カートリッジ付シャワ
ーヘッドの残留塩素除去能力を示す図である。
FIG. 7 is a diagram showing the residual chlorine removal capability of a shower head with a sustained-release drug cartridge according to the prior art.

【図8】図3の薬剤徐放カートリッジ付シャワーヘッド
が備える薬剤徐放カートリッジの種々の形態を示す、薬
剤徐放カートリッジの縦断面図である。
8 is a vertical cross-sectional view of a sustained drug release cartridge showing various forms of a sustained drug release cartridge included in the shower head with a sustained drug release cartridge of FIG.

【図9】薬剤徐放カートリッジの形態の相違が、図3の
薬剤徐放カートリッジ付シャワーヘッドの残留塩素除去
能力に与える影響を示す図である。
FIG. 9 is a diagram showing the influence of the difference in the form of the drug sustained release cartridge on the residual chlorine removing ability of the shower head with the drug sustained release cartridge of FIG. 3.

【符号の説明】[Explanation of symbols]

1 補給水用配水管 1a 膨出部 2 薬剤徐放カートリッジ 2a 多孔質膜 3 クーリングタワー本体 4a、4b 循環水配管 5 ポンプ 6 接続金具 7 空気弁 8 水抜弁 9 揺動蓋 21 薬剤徐放カートリッジ付シャワーヘッド 22 第1部分 23 第2部分 24 水抜弁 25 薬剤徐放カートリッジ 25b 多孔質膜 1 Water distribution pipe for makeup water 1a Bulging part 2 Drug sustained release cartridge 2a Porous membrane 3 Cooling tower body 4a, 4b Circulating water piping 5 Pump 6 Connection fitting 7 Air valve 8 Drain valve 9 Swing lid 21 Shower with drug sustained release cartridge Head 22 First part 23 Second part 24 Drain valve 25 Drug sustained release cartridge 25b Porous membrane

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 補給水用配水管と、補給水用配水管が接
続するクーリングタワー本体と、水溶性の液状の殺菌剤
又は水溶性の殺菌剤と該殺菌剤の飽和水溶液とが充填さ
れた空気層を含まない硬質材容器と、硬質材容器に形成
された単一の開口と、該開口を覆う多孔質膜とを有する
薬剤徐放カートリッジとを備え、薬剤徐放カートリッジ
は前記開口を補給水用配水管の流路に連通させ、且つ前
記開口を前記流路の上流側へ差し向けた状態で補給水用
配水管に装着されていることを特徴とする空調用クーリ
ングタワー。
1. A makeup water distribution pipe, a cooling tower main body to which the makeup water distribution pipe is connected, a water-soluble liquid germicide or an air filled with a water-soluble germicide and a saturated aqueous solution of the germicide. A drug sustained release cartridge having a layer-free hard material container, a single opening formed in the hard material container, and a porous membrane covering the opening is provided, and the drug sustained release cartridge fills the opening with makeup water. An air conditioning cooling tower, wherein the cooling water supply pipe is attached to a makeup water distribution pipe in a state of being connected to the flow passage of the water distribution pipe and directing the opening toward the upstream side of the flow passage.
【請求項2】 薬剤徐放カートリッジは補給水用配水管
の外側に装着され、薬剤徐放カートリッジの開口近傍部
は補給水用配水管内へ差し込まれていることを特徴とす
る請求項1に記載の空調用クーリングタワー。
2. The medicine sustained release cartridge is mounted on the outside of the makeup water distribution pipe, and the vicinity of the opening of the medicine sustained release cartridge is inserted into the makeup water distribution pipe. Cooling tower for air conditioning.
【請求項3】 薬剤徐放カートリッジは一端が閉鎖され
他端が開放された筒体であり、薬剤徐放カートリッジは
補給水用配水管内に配設されており、薬剤徐放カートリ
ッジと補給水用配水管の囲壁との間に隙間があることを
特徴とする請求項1に記載の空調用クーリングタワー。
3. The drug sustained-release cartridge is a cylinder body having one end closed and the other end open, and the drug sustained-release cartridge is disposed in a water supply pipe for makeup water. The cooling tower for air conditioning according to claim 1, wherein a gap is provided between the water distribution pipe and the surrounding wall.
【請求項4】 補給水用配水管から薬剤徐放カートリッ
ジへ流入する水量を調節する水量調節装置を備えること
を特徴とする請求項1乃至3の何れか1項に記載の空調
用クーリングタワー。
4. The cooling tower for air conditioning according to claim 1, further comprising a water amount adjusting device that adjusts the amount of water flowing from the makeup water distribution pipe into the drug sustained release cartridge.
【請求項5】 空調用クーリングタワーの停止時に薬剤
徐放カートリッジから殺菌剤が漏出するのを防止する殺
菌剤漏出防止装置を備えることを特徴とする請求項1乃
至4の何れか1項に記載の空調用クーリングタワー。
5. The disinfectant leakage prevention device for preventing leakage of the disinfectant from the drug sustained release cartridge when the cooling tower for air conditioning is stopped, according to any one of claims 1 to 4. Cooling tower for air conditioning.
JP27971096A 1995-11-02 1996-10-22 Cooling tower for air conditioner Pending JPH09184690A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27971096A JPH09184690A (en) 1995-11-02 1996-10-22 Cooling tower for air conditioner

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-308581 1995-11-02
JP30858195 1995-11-02
JP27971096A JPH09184690A (en) 1995-11-02 1996-10-22 Cooling tower for air conditioner

Publications (1)

Publication Number Publication Date
JPH09184690A true JPH09184690A (en) 1997-07-15

Family

ID=26553456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27971096A Pending JPH09184690A (en) 1995-11-02 1996-10-22 Cooling tower for air conditioner

Country Status (1)

Country Link
JP (1) JPH09184690A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104482777A (en) * 2014-12-10 2015-04-01 清华大学 Greenhouse type cooling tower
CN111065604A (en) * 2017-08-28 2020-04-24 松下知识产权经营株式会社 Chemical supply device and water purification system using same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104482777A (en) * 2014-12-10 2015-04-01 清华大学 Greenhouse type cooling tower
CN111065604A (en) * 2017-08-28 2020-04-24 松下知识产权经营株式会社 Chemical supply device and water purification system using same

Similar Documents

Publication Publication Date Title
CN106104118B (en) It is a kind of for the water distribution of tap, opening and pass hull closure
US11045829B2 (en) Self-sealing shower head with disinfectant
JPH04500171A (en) Chemical agent supply device for swimming pool
WO1999009265A1 (en) Cleaning water discharge apparatus
JPH09182684A (en) Water tank provided with chemical sustained release device
US20030056812A1 (en) Method and apparatus for cleaning air handling systems
JPH09187777A (en) Drinking water quality improving device
JPH09184690A (en) Cooling tower for air conditioner
JPH09184181A (en) Hot water washing closet seat
EP3350380B1 (en) Method of desinfecting a drain trap
JPH09187681A (en) Shower head with chemical slow discharging function and chemical slow discharge cartridge
WO2006062874A2 (en) In-line fluid treatment device and system
US20180354816A1 (en) Ion exchange water softener
JPH09187680A (en) Laboratory faucet with detergent slow discharging function
JPH09184179A (en) Stool with chemical slow releasing function
JP2001300357A (en) Shower head provided with chemical controlled-release function and chemical controlled-release cartridge
JP3121951U (en) Nano bubble water sterilizer
JPH0823960A (en) Device for testing environment
KR20220063921A (en) A Vinegar-water Shower Device
JP4481841B2 (en) Drug dissolved water supply device
US2097092A (en) Apparatus for dispensing hypochlorites
JPH0213934U (en)
EP3208392A1 (en) Backflow prevention device for water softener
JP3563124B2 (en) Waterproof shower head
JP2004097972A (en) Chemical agent adding apparatus